financial results
Abbott Q4 Diagnostics Revenues Fall 26 Percent on Declining COVID-19 Sales
The company announced that its total revenues for the quarter declined 12 percent, while revenues for the full year rose 1 percent.
Danaher Q4 Revenues Rise 3 Percent Despite Difficulties in China
The firm's Life Sciences segment saw 8 percent growth year over year, while the Diagnostics sector rose 3 percent in the quarter.
Oxford Nanopore Technologies Expects 2022 Revenue to Rise 49 Percent
The company expects 2022 revenue to be approximately £199.0 million, including around £147.0 million in life science research tools revenue.
Illumina Seeing Strong NovaSeq X Demand, Reports Preliminary Q4 Revenues Down 1 Percent
Illumina expects to ship between 40 and 50 of its new NovaSeq X instruments in the first quarter and more than 300 throughout 2023.
Berkeley Lights Misses 2022 Revenue Estimates
The company blamed delayed Beacon platform placements and lower-than-expected partnership and service contract revenues for the disappointing results.
Jan 9, 2023
CareDx Preliminary Q4 Revenues up 4 Percent
Nov 16, 2022